The Food and Drug Administration (“FDA”) has removed semaglutide from its drug shortage list after the agency determined the current supply of ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Novo Nordisk partners with telehealth ...

The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...

The table below is a review of notable updates that occurred in April 2025 for investigational products in development (not an inclusive list). Click on ...

A major clinical trial reveals Wegovy a popular weight loss drug also treats serious liver disease MASH—reducing liver inflammation and scarring in most patients ...

Ozempic (semaglutide) is an injectable medication initially designed to manage ... This service made our list of the best telemedicine companies. Among the reasons we like it is that PlushCare ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

This marks a shift in the agency's approach to treating the global obesity problem. Read more at straitstimes.com. Read more ...